Par Drugs and Chemicals Limited

Web: pardrugs.com NSE: PAR SECTOR: Healthcare - Pharmaceuticals & Biotechnology | Add Note | View Notes

163 5(-3%)

Volume

4k as on 23, Jun

Open

206

High

210

Low

202

168

VWAP

52 Week High

180

52 Week Low

Viand Research Rating

Quality Score

72/100

Growth Score

53/100

Valuation Score

50/100

Momentum Score

45/100

Analyst Recommendations

BUY/SELL

Hold | Buy | Strong Buy

Analyst Price Target

Market Cap (cr)

201

No. of Shares

1.23

P/E

P/B

Face Value

Div. Yield

Book Value (TTM)

CASH

DEBT

EPS (TTM)

ROE

ROCE

Profit Growth

Listing Date

16-Sep-21

Promoter Holding

73.41%

FII Holding

DII Holding

0.09%

Price Chart

Price Performance

1 Week1%

1 Month9%

3 Months11%

6 Months2%

1 Year2%

YTD2%

Moving Average

5 Day SMA95

10 Day SMA92

20 Day SMA90

30 Day SMA90

50 Day SMA91

61 Day SMA90

80 Day SMA0

200 Day SMA0

PIVOT LEVEL

	Standard	Camarilla	Fibonacci	Woodie's
Resistance 3	99	95	98	99
Resistance 2	98	95	97	98
Resistance 1	96	95	96	96
Pivot Point	95	95	95	95
Support 1	94	94	94	94
Support 2	92	94	93	92
Support 3	91	94	92	91

Competitors/Peers

#	Symbol	MCAP	LTP	1W	1M	6M	1Y	P/E	Ind PE	Debt/Eq	NP Qtr Rs.Cr.
1	SUNPHARMA	4,56,655	1899	0%	2%	9%	21%	37	57.7	0.07	11509
2	DIVISLAB	2,43,196	9161	2%	8%	44%	51%	69	57.7	0	2568
3	TORNTPHARM	1,84,303	4846	2%	3%	12%	36%	72	57.7	1.79	2138
4	APOLLOHOSP	1,24,834	8650	1%	1%	12%	10%	58	57.7	0.9	2003
5	ZYDUSLIFE	1,12,897	1132	4%	2%	26%	13%	20	57.7	0.46	5124
6	CIPLA	1,11,346	1385	2%	5%	3%	12%	22	57.7	0.02	3862
7	LAURUSLABS	99,634	1844	3%	3%	75%	114%	0	57.7	0.48	890
8	DRREDDY	96,962	1151	2%	2%	11%	8%	20	57.7	0.2	4158
9	MAXHEALTH	96,646	985	1%	10%	8%	14%	0	57.7	0.32	1442
10	LUPIN	96,620	2113	1%	11%	8%	10%	23	57.7	0.29	5355
Load More

Shareholding Pattern (%)

	Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023	Jun 2023	Mar 2023	Dec 2022	Sep 2022	Jun 2022	Mar 2022	Dec 2021	Sep 2021
Promoters	(0.01) 73.41%	(0.01) 73.41%	(0.01) 73.41%	(0.01) 73.37%	(0.01) 73.37%	(0.01) 73.37%	(0.01) 73.37%	(-0.81) 73.37%	(0.01) 74.21%	(0.01) 74.21%	(0.01) 74.21%	(0.01) 74.21%	(0.01) 74.21%	(0.01) 74.21%	(0.01) 74.21%	(0.01) 74.21%	(0.01) 74.21%	(0.21) 74.21%	(0.11) 73.98%	(0.01) 73.86%
FIIs	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(-0.11) 0.00%	(-0.21) 0.09%	(0.31) 0.32%	(0.01) 0.07%	(0.11) 0.07%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%
DIIs	(0.11) 0.09%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(-0.11) 0.00%	(0.11) 0.05%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(-0.11) 0.00%	(0.11) 0.12%	(0.11) 0.05%	(0.01) 0.00%	(0.01) 0.00%
Public	26.51%	26.59%	26.59%	26.63%	26.63%	26.63%	26.63%	26.54%	25.47%	25.68%	25.73%	25.79%	25.79%	25.79%	25.79%	25.79%	25.68%	25.75%	26.02%	26.13%
No. of Shareholders	12,782	13,222	13,761	14,280	14,887	15,472	17,189	8,757	8,022	7,403	7,020	5,902	5,686	5,585	5,676	5,071	4,262	4,034	3,514	1,382

Quarterly Results

	Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023	Jun 2023	Mar 2023	Dec 2022	Sep 2022	Jun 2022	Mar 2022	Dec 2021	Sep 2021
Sales	31.28	19.61	29.34	28.66	26.05	22.33	21.38	34.66	22.61	22.82	24	25.89	22.93	24.49	22.93	24.82	23.51	22.08	16.92	19.59
Sales Growth % (YoY)	20.1%	-12.2%	37.2%	-17.3%	15.2%	-2.2%	-10.9%	33.9%	-1.4%	-6.8%	4.7%	4.3%	-2.5%	10.9%	35.5%	26.7%	42.7%	36.2%	4%	14.1%
Sales Growth % (QoQ)	59.5%	-33.2%	2.4%	10%	16.7%	4.4%	-38.3%	53.3%	-0.9%	-4.9%	-7.3%	12.9%	-6.4%	6.8%	-7.6%	5.6%	6.5%	30.5%	-13.6%	-
Expenses	24.91	18.17	23.29	22.6	22.49	19.9	19.95	23.25	18.37	16.72	18.77	18.53	18.79	19.1	19.7	18.92	19.81	17.56	13.36	15.55
Operating Profit	6.37	1.44	6.05	6.06	3.56	2.43	1.43	11.41	4.24	6.1	5.23	7.36	4.14	5.39	3.23	5.9	3.7	4.52	3.56	4.04
OPM %	20.36	7.34	20.62	21.14	13.67	10.88	6.69	32.92	18.75	26.73	21.79	28.43	18.05	22.01	14.09	23.77	15.74	20.47	21.04	20.62
Other Income	0.94	0.36	1.33	0.48	1.84	0.79	0.27	1.02	0.07	-0.05	0.23	0.05	0.01	0.03	0.04	0.02	0.15	0.07	0.05	0.03
Interest	0.02	0.04	0.01	0.05	0.02	0.02	0.01	0.03	0.02	0.05	0.02	0.03	0.02	0.03	0.03	0.03	0.05	0.09	0.1	0.23
Depreciation	0.96	0.93	0.93	0.94	0.9	0.92	0.91	0.91	0.9	0.89	0.87	0.85	0.83	0.85	0.74	0.91	0.73	0.87	0.77	0.83
Profit before tax	6.33	0.83	6.44	5.55	4.48	2.28	0.78	11.49	3.39	5.11	4.57	6.53	3.3	4.54	2.5	4.98	3.07	3.63	2.74	3.01
Tax %	25.59	-3.61	25.47	25.59	25.67	27.63	24.36	25.15	25.07	27.2	25.16	25.27	25.15	24.01	25.2	25.1	25.08	33.06	22.63	26.25
Net Profit	4.71	0.85	4.8	4.13	3.33	1.65	0.58	8.6	2.53	3.72	3.42	4.89	2.47	3.45	1.87	3.73	2.29	2.42	2.12	2.22
Net Profit Growth % (QoQ)	454.1%	-82.3%	16.2%	24%	101.8%	184.5%	-93.3%	239.9%	-32%	8.8%	-30.1%	98%	-28.4%	84.5%	-49.9%	62.9%	-5.4%	14.2%	-4.5%	-
Net Profit Growth % (YoY)	41.4%	-48.5%	727.6%	-52%	31.6%	-55.6%	-83%	75.9%	2.4%	7.8%	82.9%	31.1%	7.9%	42.6%	-11.8%	68%	-	-	-	-
TTM Net Profit	14.49	13.11	13.91	9.69	14.16	13.36	15.43	18.27	14.56	14.5	14.23	12.68	11.52	11.34	10.31	10.56	9.05	6.76	4.34	0
EPS in Rs	3.83	0.69	3.9	3.36	2.71	1.34	0.47	6.99	2.06	3.02	2.78	3.97	2.01	2.8	1.52	3.03	1.86	1.97	1.72	1.8

Profit and Loss

	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014	Mar 2012
Sales	104	101	96	96	75	61	56	46	42	49	33	33	27	19
Sales Growth %	2.7%	5.6%	-0.1%	27.6%	23.6%	8.8%	20.6%	9.3%	-13.1%	46.6%	0%	21.9%	-	23.7%
Expenses	87	81	73	78	59	45	46	38	34	40	26	26	20	15
Operating Profit	17	20	23	18	16	16	9	8	8	8	7	7	7	3
OPM %	17	19	24	19	22	26	17	18	19	17	22	22	27	18
Other Income	4	2	0	0	0	2	0	0	0	0	0	0	0	0
Interest	0	0	0	0	0	1	1	2	2	2	4	4	4	1
Depreciation	4	4	3	3	3	3	3	3	3	3	3	2	2	1
Profit before tax	17	18	20	15	13	15	6	3	3	3	1	1	1	2
Tax %	24	26	26	25	27	21	21	24	42	42	58	27	40	34
Net Profit	13	13	14	11	9	12	5	3	2	2	0	1	1	1
Net Profit Growth %	-	-7.1%	27.3%	22.2%	-25%	140%	66.7%	50%	-	-	-100%	-	-	-
EPS in Rs	10.65	10.86	11.78	9.21	7.49	9.44	3.87	2.79	2.78	3.43	0.78	1.65	1.33	2.07
Dividend Payout %	0	0	0	0	0	0	32	0	0	0	0	0	0	0

Cash Flows

	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014	Mar 2012
Cash from Operating Activity	16	16	20	13	8	12	8	2	4	9	7	9	5	1
Cash from Investing Activity	-2	-25	-6	-7	-3	0	-1	0	-1	-2	0	0	-6	-7
Cash from Financing Activity	0	0	0	0	-10	2	1	-2	-4	-8	-5	-9	2	6
Net Cash Flow	14	-9	14	6	-5	14	7	0	0	-1	1	-1	1	0

Balance Sheet

	Mar 2026	Sep 2025	Mar 2025	Sep 2024	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014	Mar 2012
Equity Capital	12	12	12	12	12	12	12	6	6	4	3	3	3	3	3	3
Reserves	100	94	87	84	73	59	48	46	34	25	12	11	9	9	8	6
Borrowings	0	0	0	0	0	0	0	8	6	12	29	31	36	38	44	16
Other Liabilities	17	21	20	19	16	18	19	16	13	11	10	12	10	9	7	4
Total Liabilities	129	128	119	116	102	89	79	76	60	51	54	56	58	59	61	29
Fixed Assets	36	38	39	40	41	38	34	30	34	36	39	42	43	45	47	14
CWIP	1	0	0	0	0	0	0	5	1	0	0	0	0	0	0	6
Investments	27	27	25	26	0	0	0	0	0	0	0	0	0	0	0	0
Other Assets	65	63	55	50	60	50	44	42	25	15	15	14	15	13	14	9
Total Assets	129	128	119	116	102	89	79	76	60	51	54	56	58	59	61	29

Delivery

Delivery Data: PAR

#	Date	87 107% 180	Value (Cr)	Q/T 88	Del 57	Del 2
1	3-Sep	165	12	51	25	3
2	2-Sep	168	24	71	15	4
3	1-Sep	141	8	82	26	2
4	31-Aug	117	4	59	39	1
5	28-Aug	100	0	47	72	0
6	27-Aug	100	0	153	98	0
7	26-Aug	100	0	67	69	0
8	25-Aug	101	0	53	59	0
9	24-Aug	101	0	50	75	0
10	21-Aug	101	0	35	60	0
11	20-Aug	102	0	48	84	0
12	19-Aug	101	0	46	62	0
13	18-Aug	101	0	114	73	0
14	17-Aug	101	0	65	77	0
15	14-Aug	102	0	33	60	0
16	13-Aug	99	0	51	60	0
17	12-Aug	103	0	66	60	0
18	11-Aug	100	0	53	57	0
19	10-Aug	104	1	58	62	0
20	7-Aug	98	0	31	71	0
21	6-Aug	101	0	32	56	0
22	5-Aug	99	0	46	83	0
23	4-Aug	99	0	32	81	0
24	3-Aug	99	0	29	71	0
25	31-Jul	99	0	26	74	0
26	30-Jul	99	0	45	43	0
27	29-Jul	96	0	45	63	0
28	28-Jul	95	0	34	83	0
29	27-Jul	94	0	44	74	0
30	24-Jul	94	0	52	79	0
31	23-Jul	96	0	29	79	0
32	22-Jul	98	0	61	48	0
33	21-Jul	100	0	69	78	0
34	20-Jul	103	0	33	44	0
35	17-Jul	105	4	72	21	1
36	16-Jul	95	1	63	56	0
37	15-Jul	102	3	75	26	1
38	14-Jul	91	0	112	78	0
39	13-Jul	92	0	80	76	0
40	10-Jul	90	0	39	75	0
41	9-Jul	90	0	22	92	0
42	8-Jul	89	0	28	85	0
43	7-Jul	91	0	41	80	0
44	6-Jul	90	0	50	79	0
45	3-Jul	91	0	42	81	0
46	2-Jul	89	0	31	90	0
47	1-Jul	90	0	26	74	0
48	30-Jun	90	0	51	86	0
49	29-Jun	88	0	23	87	0

Daily Market Cap

Date	Total Market Cap	Change	Chg %
03-Sep	201c	33c	19.55
01-Sep	168c	24c	16.76
31-Aug	144c	22c	17.98
27-Aug	122c	98L	0.80
26-Aug	123c	1L	0.01
25-Aug	123c	2c	1.95
24-Aug	126c	62L	0.49
21-Aug	126c	2c	1.49
19-Aug	124c	1c	1.00
18-Aug	123c	37L	0.30
17-Aug	123c	4c	2.95
14-Aug	126c	1c	0.93
13-Aug	125c	2c	1.85
12-Aug	128c	74L	0.58
11-Aug	127c	0	0
10-Aug	127c	5c	3.98
07-Aug	122c	1c	1.02
06-Aug	121c	1c	0.86
05-Aug	122c	2L	0.02
04-Aug	122c	62L	0.51
03-Aug	121c	58L	0.48
31-Jul	121c	2c	1.98
30-Jul	123c	4c	3.11
29-Jul	119c	1c	1.07
28-Jul	118c	2c	1.88
27-Jul	116c	87L	0.76
24-Jul	115c	0	0

Stock Checklist

Price is above from 52 week high low average: 84%

Stock is trading above all short term SMAs: YES

Stock is trading above all long term SMAs: YES

Stock is Consistently Improving Long Term: NO

FII purchased in last quarter: NO

Promoters are buying the stock: NO

Mutual Fund Holdings

No mutual fund holding data available.

Strategy Builder

Bulk Deals

Events

News

Exchange Filings

Annual Reports

Ratings & Research Reports

Concalls

Announcements

NseIndia | Trendlyne | Screener | TradingView